The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model

R. Elmor, W. Sandulli, C. A. Carter

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmacoeconomics
Volume35
StatePublished - Jan 1 2017

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this